Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2025 08:00 ET | Source: Alzamend Neuro, Inc.

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs; Net Cash Financings Year-Ended April 30, 2025, $10.4 Million
February 13, 2018 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018

TEL-AVIV, Israel and RALEIGH, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical...
February 26, 2015 07:50 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results

Key Highlights Include: Strong cash position of over $34 million, following completion of a $14.4 million U.S. public offering in February 2015 With three ongoing Phase III clinical...
February 19, 2015 08:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26, 2015

TEL-AVIV, Israel, Feb. 19, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...